McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

AllStripes: How this HealthTech Company Leverages Science to Advance Rare Disease Research (Pt. 1 & Pt. 2)

by McKesson Ventures | Dec 14, 2021 | Portfolio News

A two-part interview with AllStripes co-founder Nancy Yu on PatientWorthy went in depth about Yu’s background, why she started the company, and plans for the future. It begins by highlighting her interest in how science and technology interact with one another. Yu...

THCB Spotlights: Chris Gervais, CTO of Kyruus

by McKesson Ventures | Nov 18, 2021 | Portfolio News

Kyruus has grown quite a bit since it first started as a hospital appointment scheduling platform, and the company aims to continue that trend with its recent acquisition of HealthSparq. With this move, the company plans to bridge the gap between providers and payers...

AI: Leveraging Wearables and Other Patient-Generated Data in Research

by McKesson Ventures | Nov 15, 2021 | Portfolio News

Luca Foschini, PhD, is chief data scientist and co-founder at Evidation Health. In a recent interview he discussed how artificial intelligence interacts with patient-generated data to create advancements in clinical studies for pharmaceutical and biotech companies....

How Hims & Hers built a business entirely centered on telehealth

by McKesson Ventures | Nov 3, 2021 | Portfolio News

Healthcare IT News recently interviewed Hims & Hers Chief Operating Officer Melissa Baird about how the company has built its brand around telehealth but still has its origins in helping people deal with conditions that are uncomfortable to talk about—sexual...

Transforming the Rare Disease Landscape with Data

by McKesson Ventures | Oct 1, 2021 | Portfolio News

AllStripes, formerly known as RDMD, recently completed a $50 million venture round, which it will use to launch 100 new rare disease research programs. Global Genes recently interviewed AllStripes Co-founder and CEO Nancy Yu about the growing efforts around patient...

Matternet’s automated drone-docking station makes its real-life debut in Switzerland

by McKesson Ventures | Sep 30, 2021 | Portfolio News

Matternet has debuted its Matternet Station automated landing space and payload control tower at a hospital in Lugano, Switzerland. Looking something like a 10-foot-tall flower, the Matternet Station provides a safe place for a cargo drone to land, swap out its...
Page 8 of 85« First«...678910...203040...»Last »

Recent Posts

  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
  • Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
  • Reimagine Care and Tampa General Hospital Cancer Institute Launch Virtual Cancer Care Collaboration to Reduce Hospitalizations and Elevate Patient Support
  • Midi Health CEO Joanna Strober Discusses Accessible Menopause Care with McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
  • Atropos Health Launches the Atropos Evidence™ Agent with Microsoft Teams to Surface Personalized Evidence during Multidisciplinary Care Team Collaborations
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

 

Contact Us

In the News

CancerIQ CEO Feyi Ayodele Named to Modern Healthcare’s 2024 Innovators List

Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics on Diagnostic Indicators Used for Checkpoint Inhibitor Therapy

Emerging Leaders 2024: Carrie Williams, McKesson Ventures

Forbes’ 2024 List of America’s Best Startup Employers

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
  • Follow